Om du vill rapportera en biverkning gällande en av Lillys produkter, kontakta oss via e-post på DK_PHv@lilly.com eller på telefon +45 4526 6040. Har du ytterligare medicinska frågor gällande en av Lillys produkter, kontakta oss via länken ovan.
Zypadhera ® (olanzapin)
Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska
Coronavirus disease 2019 (COVID-19) is an infectious respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously referred to as "2019 novel coronavirus."1
Lilly has not studied the use of olanzapine long-acting injection in patients with COVID-19 nor in patients at risk of contracting COVID-19.
Warnings and Precautions
Caution should be exercised in patients with low leukocyte and/or neutrophil counts for any reason, in patients
receiving medicines known to cause neutropenia, in patients with
with a history of drug-induced bone marrow depression/toxicity,
with bone marrow depression caused by concomitant illness, radiation therapy or chemotherapy and
with hypereosinophilic conditions or with myeloproliferative disease.2
Neutropenia has been reported commonly when olanzapine and valproate are used concomitantly.2
In addition, please note the following common adverse events (≥ 1/100 to < 1/10) that may occur in patients being treated with olanzapine pamoate. The following list includes adverse reactions observed from spontaneous reporting and in clinical trials. For full list of undesirable effects, please refer to section 4.8 of the ZypAdhera Summary of Product Characteristics.
Pyrexia (common) (As assessed by measured values from clinical trials in the Olanzapine Integrated Database.)2
Infectious Disease Resources for COVID-19
For current information on COVID-19, please refer to
Coronavirus disease (COVID-19) outbreak on the WHO website, and
1. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed March 11, 2020.
3. Coronavirus disease (COVID-19) outbreak. World Health Organization. Accessed March 17, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
4. Coronavirus (COVID-19). Centers for Disease Control and Prevention. Accessed March 17, 2020. https://www.cdc.gov/coronavirus/2019-ncov/index.html
CDC = The Center for Disease Control
Lilly = Eli Lilly and Company
WHO = World Health Organization
Datum fӧr senaste ӧversyn 2020 M03 24